| An SI Board Since November 2014 |
| Posts |
SubjectMarks |
Bans |
Symbol |
| 5 |
1 |
0
|
ATRC |
|
AtriCure, Inc. is a medical device company providing innovative atrial fibrillation (Afib) solutions designed to produce superior outcomes that reduce the economic and social burden of atrial fibrillation.
AtriCure's Synergy(TM) Ablation System is the first and only surgical device approved for the treatment of persistent and longstanding persistent forms of Afib in patients undergoing certain open concomitant procedures.
AtriCure's AtriClip left atrial appendage management (LAAM) exclusion device is the most widely sold device worldwide that's indicated for the occlusion of the left atrial appendage. The company believes cardiothoracic surgeons are adopting its ablation and LAAM devices for the treatment of Afib and reduction of Afib related complications such as stroke. Afib affects more than 33 million people worldwide.(2) For more information visit AtriCure.com or follow us on Twitter @AtriCure.
|
|
|
